INVESTIGATING A NOVEL GAMMA DELTA (??) T CELL-BASED ...

Despite impressive outcomes for Chimeric Antigen Receptor (CAR) therapy in haematological cancers, little progress has so far been made for solid tumours. This.







p300/CBP degradation is required to disable the active AR ... - bioRxiv
In vivo experiments using an orally active p300/CBP proteolysis targeting chimera (PROTAC) degrader (CBPD-409) showed that p300/CBP ...
CAR T cell engineering impacts antigen-independent activation
Phosphorylation- dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol Cell Biol. 2003;23 ...
Contexte des systèmes automatisés - of /theses
supervision industrielle tels que les SCADA (Supervisory Control And Data Acquisition) sont fortement imprégnés de ces technologies. La principale ...



Autres Cours:

Etude de l'inhibition fonctionnelle du facteur de transcription HOXA9 ...